Target Name: BARHL1
NCBI ID: G56751
Review Report on BARHL1 Target / Biomarker Content of Review Report on BARHL1 Target / Biomarker
BARHL1
Other Name(s): BarH-like 1 | BarH like homeobox 1 | BarH-like 1 homeobox protein | BarH-like homeobox 1 | BARH1_HUMAN | OTTHUMP00000022433

Unlocking The Potential of BARHL1: A Protein with Unique Structure and Multiple Functions

BarH-like 1 (BARHL1) is a protein that is expressed in a variety of tissues, including the brain, heart, lungs, and gastrointestinal tract. It is characterized by its unique structure, which is similar to that of barley but contains a few additional amino acids. BARHL1 has been shown to play a role in a variety of physiological processes, including cell signaling, tissue repair, and inflammation. As a result, it has potential as a drug target or biomarker.

One of the unique features of BARHL1 is its structure. BARHL1 is made up of 214 amino acids and has a molecular weight of 29.9 kDa. It has a single transmembrane domain and a cytoplasmic tail. The cytoplasmic tail is composed of 11 amino acids and is involved in the regulation of BARHL1's stability and localization to the plasma membrane.

BARHL1 is involved in a variety of signaling pathways. For example, it has been shown to play a role in the regulation of cell signaling by the protein PDGF-B. PDGF-B is a potent signaling molecule that is involved in the development and maintenance of tissues, including tissues of the brain. BARHL1 has been shown to interact with PDGF-B and to regulate its activity. This suggests that BARHL1 may be a useful drug target or biomarker for the treatment of conditions that are characterized by the over-activity of PDGF-B.

BARHL1 is also involved in the regulation of tissue repair processes. After injury or damage to tissues, the body mounts a repair response, including the production of new cells and the formation of new tissues. BARHL1 has been shown to play a role in this process by regulating the production of new blood vessels that supply the site of injury. This suggests that BARHL1 may be a useful drug target or biomarker for the treatment of conditions that are characterized by the failure of the immune system to repair damaged tissue.

In addition to its role in cell signaling and tissue repair, BARHL1 is also involved in the regulation of inflammation. It has been shown to play a role in the production of pro-inflammatory cytokines, such as TNF-alpha and IL-1. This suggests that BARHL1 may be a useful drug target or biomarker for the treatment of conditions that are characterized by inflammation.

Given its unique structure and its involvement in a variety of physiological processes, BARHL1 has potential as a drug target or biomarker. Studies are being conducted to determine the exact function of BARHL1 and to explore its potential as a drug or biomarker. Further research is needed to fully understand the role of BARHL1 in these processes and to determine its potential as a therapeutic agent.

Protein Name: BarH Like Homeobox 1

The "BARHL1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BARHL1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

BARHL2 | BARX1 | BARX1-DT | BARX2 | BASC complex | BASP1 | BASP1-AS1 | BASP1P1 | BATF | BATF2 | BATF3 | BAX | BAZ1A | BAZ1A-AS1 | BAZ1B | BAZ2A | BAZ2B | BAZ2B-AS1 | BBC3 | BBIP1 | BBLN | BBOF1 | BBOX1 | BBOX1-AS1 | BBS1 | BBS10 | BBS12 | BBS2 | BBS4 | BBS5 | BBS7 | BBS9 | BBSome complex | BBX | BCAM | BCAN | BCAN-AS1 | BCAP29 | BCAP31 | BCAR1 | BCAR3 | BCAR3-AS1 | BCAR4 | BCAS1 | BCAS2 | BCAS2P2 | BCAS3 | BCAS4 | BCAT1 | BCAT2 | BCCIP | BCDIN3D | BCDIN3D-AS1 | BCHE | BCKDHA | BCKDHB | BCKDK | BCL10 | BCL10-AS1 | BCL11A | BCL11B | BCL2 | BCL2A1 | BCL2L1 | BCL2L10 | BCL2L11 | BCL2L12 | BCL2L13 | BCL2L14 | BCL2L15 | BCL2L2 | BCL2L2-PABPN1 | BCL3 | BCL6 | BCL6B | BCL7A | BCL7B | BCL7C | BCL9 | BCL9L | BCLAF1 | BCLAF3 | BCO1 | BCO2 | BCOR | BCORL1 | BCORP1 | BCR | BCR(BACURD1) E3 ubiquitin ligase complex | BCR(BACURD3) E3 ubiquitin ligase complex | BCR(KLHL12) E3 ubiquitin ligase complex | BCR(KLHL20) E3 ubiquitin ligase complex | BCR(KLHL22) E3 ubiquitin ligase complex | BCR(KLHL9-KLHL13) E3 ubiquitin ligase complex | BCRP2 | BCRP3 | BCRP4 | BCRP5 | BCRP6 | BCRP7